Tramazoline

CAS: 1082-57-1

Ref. 3D-FT177526

Información del producto

• Nombre: Tramazoline
• Sinónimos: 1H-Imidazol-2-amine, 4,5-dihydro-N-(5,6,7,8-tetrahydro-1-naphthalenyl)-, 2-(5,6,7,8-Tetrahydro-1-naphthylamino)-2-imidazoline, 2-Imidazolin-2-Yl(5,6,7,8-Tetrahydro-1-Naphthyl)Amine, 2-Imidazoline, 2-[(5,6,7,8-tetrahydro-1-naphthyl)amino]-, 4,5-Dihydro-N-(5,6,7,8-tetrahydro-1-naphthalenyl)-1H-imidazol-2-amine, N-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine, Rhinol, Rhynaspray, Tobispray, Tramazolin

Descripción

Tramazoline is a centrally acting respiratory stimulant that is used in the treatment of central apnea. It is believed to stimulate the cholinergic receptors and increase the activity of gamma-aminobutyric acid, which stimulates nerve cells to produce dopamine. Tramazoline has been shown to be effective in the treatment of occipital cortex tissue culture and has also demonstrated a pressor effect on rat striatal fat cells. Tramazoline may act as an absorption enhancer through its nitrogen atoms, which would allow it to penetrate into the nasal cavity.
!--

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 215.29 g/mol
• Fórmula: C₁₃H₁₇N₃
• Pureza: Min. 95%
• InChI: InChI=1S/C13H17N3/c1-2-6-11-10(4-1)5-3-7-12(11)16-13-14-8-9-15-13/h3,5,7H,1-2,4,6,8-9H2,(H2,14,15,16)
• Clave InChI: InChIKey=QQJLHRRUATVHED-UHFFFAOYSA-N
• SMILES: c1cc2c(c(NC3=NCCN3)c1)CCCC2